Table 10 Disease specific utility values used in PRIMEtime CE
PRIMEtime CE disease outcome | PRIMEtime CE ICD-10 codes | Equivalent ICD-9 codes | Available utility decrement from Sullivan et al. [80]a | Utility value used in PRIMEtime CE (SE) |
|---|---|---|---|---|
Ischaemic heart disease | I20-I25 | 410–414 | 410: −0.063 411: −0.087 412: −0.037 413: −0.085 414: −0.063 | Incident case: −0.071 (0.024) Prevalent: −0.070 (0.015) |
Stroke | I60-I69 | 430–438 | 433: −0.035 435: − 0.033 436: − 0.117 437: − 0.031 438: − 0.073 | Incident: − 0.094 (0.019) Prevalent: − 0.046 (0.031) |
Type two diabetes | E11, E14 | 250.×0 | 250: − 0.071 | − 0.071 (0.005) |
Breast cancer | C50 | 174, 175 | 174: − 0.019 | − 0.019 (0.014) |
Colon cancer | C18-C20 | 153, 154.0, 154.1 | 153: − 0.067 | − 0.067 (0.017) |
Lung cancer | C34 | 162.2–162.9 | 162: − 0.119 | −0.119 (0.043) |
Stomach cancer | C16 | 151 | 151: −0.071 | −0.071 (0.105) |
Liver cancer | C22 | 155 | 155: −0.093 | −0.093 (0.044) |
Kidney cancer | C64 | 189.0 | 189: −0.048 | −0.048 (0.041) |
Pancreatic cancer | C25 | 157 | 195: −0.086 | −0.086 (0.027) |
Liver disease | K70, K74 | 571.0–571.3, 571.5, 571.6, 571.9 | 571: −0.083 | −0.083 (0.031) |